SCHEMBL24334232

SCHEMBL24334232

CCOc1ccccc1S(=O)(=O)NC(=O)c1cc2ccc(N3CCCCC3)cc2o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.46
RAB9A P51151 4/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 6/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPK1 P28482 2/20 0.44
GAA P10253 1/20 0.42
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.40
TP53 P04637 2/20 0.39
ATM Q13315 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
DRD3 P35462 2/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
HTR1A P08908 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334441 0.92 MAPT (0.48) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24334306 0.89 GAA (0.42) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL29469699 0.88 GAA (0.40) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24333686 0.88 GAA (0.41) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24333782 0.88 GAA (0.41) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24334435 0.88 GAA (0.41) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24334290 0.87 GAA (0.41) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24333671 0.87 GAA (0.41) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL29469657 0.87 GAA (0.41) NPC1RAB9AKMT2AMAPTSMN1; SMN2
SCHEMBL24334431 0.86 GAA (0.40) NPC1RAB9AKMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed